Stott D I, Munro A J
Biochem J. 1972 Aug;128(5):1221-7. doi: 10.1042/bj1281221.
We propose that pyrrolid-2-one-5-carboxyl-tRNA is not involved in the initiation of protein synthesis in eukaryotic cells and that the N-terminal pyrrolid-2-one-5-carboxylic acid group of an IgG (immunoglobulin G) (that secreted by the mouse plasmacytoma Adj PC5) is formed by the enzymic cyclization of the N-terminal glutamine of the heavy chain of the completed IgG molecule and that the cyclization takes place inside the cell. We base these conclusions on the following evidence. (1) Pyrrolidonecarboxyl-tRNA was not found in incorporation experiments with rat liver preparations and [U-(14)C]-pyrrolidonecarboxylic acid, glutamic acid and glutamine, even though an incorporation extent of less than 2% of the total products could have been detected. (2) Double-labelling experiments showed that less than 8% of the nascent peptides of heavy chains (those obtained by precipitation by the antibody to Fc fragment) began with pyrrolidonecarboxylic acid. (3) Further double-labelling experiments showed that 60-66% of the heavy chains of the completed intracellular IgG molecule began with pyrrolidonecarboxylic acid after both 1 and 5h of labelling. (4) The IgG, after secretion by plasmacytoma Adj PC5, was found to have the sequence [unk]Glu- Val-Gln-Leu- at the N-termini of the heavy chains.
我们提出,吡咯烷 - 2 - 酮 - 5 - 羧基 - tRNA不参与真核细胞中蛋白质合成的起始过程,并且IgG(免疫球蛋白G)(由小鼠浆细胞瘤Adj PC5分泌)的N端吡咯烷 - 2 - 酮 - 5 - 羧酸基团是由完整IgG分子重链的N端谷氨酰胺经酶促环化形成的,且环化发生在细胞内。我们基于以下证据得出这些结论。(1)在用大鼠肝脏制剂以及[U - (14)C] - 吡咯烷酮羧酸、谷氨酸和谷氨酰胺进行的掺入实验中未发现吡咯烷酮羧基 - tRNA,尽管可以检测到掺入量占总产物不到2%的情况。(2)双标记实验表明,重链的新生肽(通过抗Fc片段抗体沉淀获得)中起始于吡咯烷酮羧酸的不到8%。(3)进一步的双标记实验表明,在标记1小时和5小时后,细胞内完整IgG分子的重链中有60 - 66%起始于吡咯烷酮羧酸。(4)发现浆细胞瘤Adj PC5分泌的IgG在重链的N端具有序列[未知]Glu - Val - Gln - Leu - 。